Main > RHEUMATOLOGY > Dupuytrens Disease



Dupuytrens Disease's subsections
Co: USA. 1. Treat.>Anti TNF MAb>
Company
Company Web-Site
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2018. 08.28.
Status: Phase IIB

Dupuytrens Disease's products
This section has no products